![]() |
市场调查报告书
商品编码
1873564
共轭亚麻油酸 (CLA) - 全球市场份额和排名、总收入和需求预测(2025-2031 年)Conjugated Linoleic Acid (CLA) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031 |
||||||
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
2024 年全球共轭亚麻油酸 (CLA) 市场规模估计为 5,720 万美元,预计到 2031 年将达到 8,810 万美元,在预测期(2025-2031 年)内复合年增长率为 6.5%。
本报告对近期关税调整和国际对共轭亚麻油酸 (CLA) 采取的战略反制措施的跨境产业布局、资本配置模式、区域经济相互依存关係和供应链重组进行了全面评估。
共轭亚麻油酸 (CLA) 是亚麻油酸位置异构体和几何异构体的统称。亚麻油酸是一种多效价Omega-6脂肪酸,天然存在于牛等反刍动物的肉类和乳製品中。 CLA 的特征在于其共轭双键。具体而言,它有两个双键,由一个碳单键连接,而不是多不饱和脂肪酸中常见的亚甲基间接键。生物活性最强且研究最广泛的异构体是顺式-9、反式-11 CLA(反刍亚麻油酸)和反式-10、顺式-12 CLA。这些异构体与多种生理和健康益处有关,并且是全球对 CLA 基产品需求的主要驱动力。
共轭亚麻油酸 (CLA) 主要来自两个方面:天然来源和商业性合成。天然 CLA 存在于草饲动物的肉类和乳製品中,但含量极低。然而,市售 CLA 补充剂通常是透过化学或酵素法异构化植物油(例如红花油、葵花籽油和大豆油)中的亚麻油酸而製成的。市售 CLA 产品通常是两种主要异构体各占 50% 的混合物。这些产品有多种形式,包括软胶囊、粉末和机能性食品配料。
由于科学报告显示共轭亚麻油酸(CLA)具有减少体脂、增加肌肉量、提高代谢率、改善免疫功能以及发挥抗癌、抗糖尿病和抗动脉粥样硬化作用等潜在功效,CLA在膳食补充剂和功能机能性食品食品领域备受关注。这些发现使CLA成为体重管理产品、运动营养品和一般保健品中的一种重要成分,吸引了从运动员到注重健康的老年人等广泛的消费者群体。
CLA市场可细分为膳食补充剂、功能性食品和饮料、动物饲料以及药品。其中,膳食补充剂占市场主导地位,份额最大。 CLA补充剂通常宣称具有促进脂肪燃烧、提高运动表现和维护代谢健康等功效,并且在保健食品店、药店、线上平台和超级市场均有销售。
CLA 在功能性食品和饮料中的应用正在蓬勃发展,製造商将其添加到强化乳製品、蛋白质棒和代餐等产品中,主要目标客户是希望控制体重和改善身体成分,而无需依赖药物或极端饮食限制的消费者。
畜牧饲料产业也是一个重要且不断成长的领域。饲料中添加共轭亚麻油酸(CLA)可以提高肉类和乳製品的营养价值,增加CLA含量,而CLA被认为有益于人体健康。这与消费者日益增长的对天然强化「洁净标示」食品的偏好相符。
儘管共轭亚麻油酸(CLA)的药用价值仍相对有限,但已展现出一定的潜力。对其抗发炎、抗癌和胰岛素增敏特性的研究有望为治疗製剂的开发开闢新的途径。然而,CLA的药用价值仍受限于需要进行更多确凿的临床试验、获得监管部门的核准以及成本方面的考虑。
全球主要企业包括BASF(BASF)、英诺博 (INNOBIO) 和斯蒂潘 (Stepan)(脂质营养公司)。前三大企业占了约 65% 的市场。北美市占率最大,约 40%,其次是欧洲和亚太地区,分别占 30% 和 20%。
本报告旨在对全球共轭亚麻油酸 (CLA) 市场按地区/国家、含量和应用进行全面分析,重点关注总销售量、收入、价格、市场份额和主要企业的排名。
本报告以销售量(吨)和收入(百万美元)为单位,对共轭亚麻油酸(CLA)市场规模、估算和预测进行了阐述,以2024年为基准年,并涵盖了2020年至2031年的历史数据和预测数据。报告采用定量和定性分析相结合的方法,帮助读者制定业务/成长策略,评估市场竞争格局,分析自身在当前市场中的地位,并就共轭亚麻油酸(CLA)做出明智的商业决策。
市场区隔
公司
按内容细分
应用领域
按地区
The global market for Conjugated Linoleic Acid (CLA) was estimated to be worth US$ 57.2 million in 2024 and is forecast to a readjusted size of US$ 88.1 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Conjugated Linoleic Acid (CLA) cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Conjugated Linoleic Acid (CLA) refers to a group of positional and geometric isomers of linoleic acid, a polyunsaturated omega-6 fatty acid that naturally occurs in meat and dairy products derived from ruminant animals such as cows and sheep. CLA is characterized by its conjugated double bonds - specifically, the presence of two double bonds separated by a single carbon bond, rather than the typical methylene interruption seen in most polyunsaturated fatty acids. The most biologically active and extensively studied isomers are cis-9, trans-11 CLA (rumenic acid) and trans-10, cis-12 CLA. These isomers are associated with a variety of physiological effects and health benefits, which have been the primary drivers behind the global demand for CLA-based products.
CLA is primarily obtained from two sources: natural sources and commercial synthesis. Natural CLA is found in trace amounts in meat and dairy products of grass-fed animals. However, commercial CLA supplements are generally produced by chemical or enzymatic isomerization of linoleic acid derived from vegetable oils such as safflower, sunflower, or soybean oils. The commercially available CLA products typically consist of a 50:50 mixture of the two main isomers. These products are offered in a variety of forms, including softgel capsules, powders, and functional food ingredients.
CLA gained prominence in the dietary supplement and functional food sectors due to scientific reports suggesting its potential roles in reducing body fat mass, increasing lean muscle mass, enhancing metabolic rate, improving immune function, and exerting anticancer, antidiabetic, and antiatherogenic properties. These findings have positioned CLA as a valuable ingredient in weight management products, sports nutrition, and general health supplements, attracting a broad consumer base ranging from athletes to health-conscious individuals and aging populations.
The CLA market is segmented by end-use application into dietary supplements, functional foods & beverages, animal feed, and pharmaceuticals. Among these, dietary supplements dominate the market, accounting for the largest share. CLA supplements are frequently marketed for their purported abilities to promote fat loss, enhance athletic performance, and support metabolic health. They are widely sold through health stores, pharmacies, online platforms, and supermarkets.
Functional food and beverage applications of CLA are gaining momentum, with manufacturers incorporating CLA into products such as fortified dairy items, protein bars, and meal replacements. These functional food applications are often targeted at consumers looking to manage weight or improve body composition without resorting to pharmaceuticals or extreme dieting.
Animal feed, particularly for livestock, is another important and growing segment. CLA-enriched feed is used to enhance the nutritional quality of meat and dairy products by increasing their CLA content, which is considered beneficial for human health. This aligns with the rising consumer preference for naturally fortified, "clean label" foods.
Pharmaceutical applications remain relatively limited but promising. Research into the anti-inflammatory, anticancer, and insulin-sensitizing properties of CLA could open new opportunities in the formulation of therapeutic products. However, pharmaceutical use is constrained by the need for more definitive clinical trials, regulatory approvals, and cost considerations.
Global key players of Conjugated Linoleic Acid (CLA) include BASF, INNOBIO, Stepan (Lipid Nutrition), etc. The top three players hold a share about 65%. North America is the largest market, and has a share about 40%, followed by Europe and Asia-Pacific with share 30% and 20%, separately.
This report aims to provide a comprehensive presentation of the global market for Conjugated Linoleic Acid (CLA), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Conjugated Linoleic Acid (CLA) by region & country, by Content, and by Application.
The Conjugated Linoleic Acid (CLA) market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Conjugated Linoleic Acid (CLA).
Market Segmentation
By Company
Segment by Content
Segment by Application
By Region
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Conjugated Linoleic Acid (CLA) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Content, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Conjugated Linoleic Acid (CLA) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Conjugated Linoleic Acid (CLA) in country level. It provides sigmate data by Content, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.